Publication | Closed Access

Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers

VaccinationClinical Trial SafetyHealthy Hiv-1-uninfected VolunteersPrime-boost RegimeHuman RetrovirusImmunologyAntiviral ResponseVaccine TrialVirologyAntiviral TherapyHivPolyvalent VaccineMedicine